Masafumi Inomata

21PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)South-East Asian languages (excl. Indonesian)Molecular targetsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 21, 2026
Protocol digest of a randomized controlled trial comparing transverse colectomy with extended right hemicolectomy for Stage II/III transverse colon cancer: JCOG2304 (TACTICS).

|Apr 27, 2026
Multidisciplinary Trends in Endoscopic Surgery in Japan: Insights From the 17th Nationwide Survey.

|Jan 29, 2026
Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma.

Shusaku Kurogi, Yoshiyuki Tsukamoto, Junpei Yamamura

|Jan 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603.

Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa

|Jun 24, 2025
Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial).

Yoshikuni Kawaguchi, Kiyoshi Hasegawa, Kosuke Kashiwabara

|Jan 06, 2025
Risk factors for serious postoperative complications following gastrectomy in super-elderly patients ≥85-years-old with gastric cancer: A National Clinical Database study in Japan.

Yoshitake Ueda, Shiori Nishimura, Masafumi Inomata

Pageof 4

Frequent Collaborators

9 joint publications

Tomonori Akagi

3 joint publications

Hidefumi Shiroshita

3 joint publications

Hiroshi Katayama

3 joint publications

Yusuke Kinugasa